FCM da Santa Casa de São Paulo, Alameda dos Indigenas, 228, ZIP 04059 060, São Paulo, Brazil.
Expert Rev Vaccines. 2013 Aug;12(8):903-15. doi: 10.1586/14760584.2013.814879. Epub 2013 Aug 5.
The Global Meningococcal Initiative (GMI) is an international group of scientists and clinicians with expertise in meningococcal disease (MD). It promotes MD prevention through education and research. Given geographic differences in disease epidemiology, prevention strategies (e.g., vaccination) should be country-specific to ensure local needs are met. However, regional policies/recommendations and standardized disease diagnostic criteria should be implemented to improve surveillance and control strategies, and allow for more robust data comparisons. Consequently, the GMI convened a meeting with Latin American representatives to discuss the burden of MD and vaccination practices/policies, and consider if the global GMI recommendations could be tailored. The group determined that as robust, uniform epidemiologic data are required to make informed health-policy decisions, it would be useful to first summarize the regional situation herein (including disease surveillance, case definitions, epidemiology, vaccination and outbreak control strategies) and then determine a consensus-based meningococcal case definition for use throughout the region.
全球脑膜炎球菌倡议(GMI)是一个由脑膜炎球菌病(MD)领域的科学家和临床医生组成的国际团体。它通过教育和研究促进 MD 的预防。鉴于疾病流行病学的地理差异,预防策略(例如疫苗接种)应该针对特定国家,以确保满足当地的需求。然而,应该实施区域政策/建议和标准化疾病诊断标准,以改进监测和控制策略,并允许进行更有力的数据比较。因此,GMI 召集了一次拉丁美洲代表会议,讨论 MD 的负担和疫苗接种实践/政策,并考虑是否可以调整全球 GMI 的建议。该小组确定,由于需要可靠、统一的流行病学数据来做出明智的卫生政策决策,因此首先总结该地区的情况(包括疾病监测、病例定义、流行病学、疫苗接种和暴发控制策略),然后确定一个基于共识的脑膜炎球菌病例定义,以便在整个地区使用,这将是有用的。